Copyright © 2000 by Institute of Pharmacology
Polish Academy of Sciences
Pol. J. Pharmacol., 2000, 52, 313-316
ISSN 1230-6002

Go to: Contents | Previous Article | Next Article | PJP - Home Page |


PRELIMINARY COMMUNICATION
COMBINED TREATMENT WITH NMDA ANTAGONIST, CGP 37849, AND SIGMA RECEPTOR AGONISTS, SA4503 OR DTG, DECREASES THE NEUROLEPTIC-INDUCED CATALEPSY IN RATS
Grażyna Skuza
Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, PL 31-343 Kraków, Poland

Combined treatment with NMDA antagonist, CGP 37849, and sigma receptor agonists, SA4503 or DTG, decreases the neuroleptic-induced catalepsy in rats. G. SKUZA. Pol. J. Pharmacol., 2000, 52, 313-316.

The obtained results indicate that joint administration of CGP 37849, a competitive NMDA receptor antagonist, and SA4503, a sigma1 (sigma1) receptor agonist or DTG, sigma1/2 receptor agonist, evoked anticataleptic effect at doses which were ineffective when each of the compounds was given alone.

Key words: CGP 37849, sigma agonists, neuroleptic-induced catalepsy, rat

Back to: Top | PJP - Home Page |